Sana Biotechnology (SANA) Prepaid Assets (2020 - 2026)
Sana Biotechnology (SANA) posted Prepaid Assets of $6.4 million for Q1 2026, up 4.26% sequentially from $6.1 million in Q4 2025, and up 65.81% YoY from $3.8 million in Q1 2025.
Analysis
Sana Biotechnology (SANA) Prepaid Assets (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Prepaid Assets for 7 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Prepaid Assets rose 65.81% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 65.81% YoY) and the FY2025 annual result came in at $6.1 million, up 36.17% from the prior year.
- Prepaid Assets rose to $6.4 million in Q1 2026 per SANA's latest filing, from $6.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $14.5 million in Q1 2023 and troughed at $3.8 million in Q1 2025.
- A 5-year average of $7.6 million and a median of $6.6 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 102.31% in 2022, then plunged 68.78% in 2023.
- Over 5 years, Prepaid Assets stood at $14.4 million in 2022, then slumped by 68.78% to $4.5 million in 2023, then fell by 0.2% to $4.5 million in 2024, then jumped by 36.17% to $6.1 million in 2025, then increased by 4.26% to $6.4 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.4 million, $6.1 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sana Biotechnology | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.94 Mn |
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 7.98 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | 4.49 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 6.61 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 14.37 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | 9.61 Mn |
| Mar 31, 2022 | 10.84 Mn |
| Dec 31, 2021 | 7.11 Mn |
| Sep 30, 2021 | 9.13 Mn |